Amgen Inc.
CHIMERIC RECEPTORS TO DLL3 AND METHODS OF USE THEREOF

Abstract:

Antigen binding molecules, chimeric receptors, and engineered immune cells to DLL3 are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the DLL3 antigen binding molecules and engineered immune cells.